You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Drug Price Trends for NDC 83301-0005


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 83301-0005

Drug Name NDC Price/Unit ($) Unit Date
GABAPENTIN 400 MG CAPSULE 83301-0005-01 0.04163 EACH 2025-12-17
GABAPENTIN 400 MG CAPSULE 83301-0005-03 0.04163 EACH 2025-12-17
GABAPENTIN 400 MG CAPSULE 83301-0005-02 0.04163 EACH 2025-12-17
GABAPENTIN 400 MG CAPSULE 83301-0005-02 0.04156 EACH 2025-11-19
GABAPENTIN 400 MG CAPSULE 83301-0005-03 0.04156 EACH 2025-11-19
GABAPENTIN 400 MG CAPSULE 83301-0005-01 0.04156 EACH 2025-11-19
GABAPENTIN 400 MG CAPSULE 83301-0005-03 0.04171 EACH 2025-10-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 83301-0005

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC: 83301-0005

Last updated: August 15, 2025

Introduction

The pharmaceutical landscape is continually evolving, driven by innovations, regulatory changes, and market dynamics. This analysis scrutinizes NDC 83301-0005, a specific drug identified by its National Drug Code (NDC). This report explores its market position, competitive landscape, pricing trends, regulatory environment, and future price projections, providing stakeholders with a comprehensive outlook to inform strategic decisions.

Product Overview

The NDC 83301-0005 corresponds to [insert specific drug name, formulation, and intended use if available]. While exact details depend on manufacturer filings, this medication serves a critical role in treating [indicate therapeutic areas]. Its formulation, route of administration, and patent status significantly influence its market dynamics.

Market Landscape

Market Size & Demand

The demand for [specific therapeutic class or drug name] has markedly increased owing to rising prevalence of [diseases/conditions]. According to recent epidemiological data, [provide relevant statistics and growth trends]. The global pharmaceutical market for this segment is projected to reach [value] by [year], with notable growth in [key regions such as North America, Europe, and Asia-Pacific].

Competitive Environment

The competitive landscape features several key players, notably [list major competitors], each offering alternatives with varying efficacy and pricing. Patent expiration or exclusivity status critically impacts market share and pricing strategies. Biosimilar or generic entries, where applicable, exert downward pressure on prices, whereas proprietary formulations sustain premium pricing.

Regulatory and Reimbursement Factors

Regulatory approvals, including FDA clearance, influence market entry and acceptance. Reimbursement policies, Medicaid and private insurer formulary preferences, and price negotiations directly shape achievable price points. Notably, recent shifts toward value-based pricing models impact manufacturer strategies.

Pricing Trends and Historical Data

Current Pricing Analysis

The wholesale acquisition cost (WAC) for NDC 83301-0005 hovers around $[insert current price], reflecting [drug's patent status, manufacturing costs, demand, etc.]. Historically, the product experienced price fluctuations driven by production costs, market competition, and regulatory changes.

Market Drivers Affecting Pricing

  • Supply-Demand Dynamics: Increasing demand coupled with constrained supply due to manufacturing complexities maintains or elevates prices.
  • Patent and Exclusivity: Patented periods safeguard premium pricing, while patent cliffs often precipitate significant price reductions.
  • Regional Variations: Prices differ across markets, influenced by local regulations, negotiated discounts, and purchasing power.

Impact of Biosimilars and Generics

When applicable, biosimilar or generic entries truncate profit margins in mature markets. For [specific drug], the entry of biosimilars could reduce prices by [estimated percentage], potentially impacting revenues significantly.

Price Projection Outlook

Short-Term (Next 1-2 Years)

Given current patent protection, regulatory approval processes, and demand trends, [drug name] is projected to maintain stable pricing with potential slight increases of [percentage], driven by inflation, manufacturing costs, and inflation. Price stabilization is expected unless new competitors or regulatory frameworks emerge.

Medium to Long-Term (3-5 Years)

  • Patent Expiry Impact: If patent expiration occurs within this period, a notable decline in price—potentially (30-50%)—is anticipated due to biosimilar and generic competition.
  • Regulatory and Pricing Policies: Shifts towards value-based and cost-effectiveness models could lead to negotiated price caps or discounts.
  • Market Penetration of Alternatives: Advances in therapies, including bioengineering or personalized medicine, might challenge the position of [drug name], impacting pricing.

Factors Influencing Future Prices

  • Regulatory Changes: Favorable policies could enable higher prices; stringent price controls could suppress them.
  • Market Competition: Entry of biosimilars, generics, or alternative therapies will exert downward pressure.
  • Manufacturing and Supply Chain Dynamics: Disruptions could lead to price volatility.

Strategic Implications and Recommendations

  • Monitor Patent and Regulatory Milestones: Anticipate expiry dates and potential biosimilar entries to forecast price reductions.
  • Engage in Reimbursement Negotiations: Leverage clinical data showcasing value to secure favorable reimbursement terms.
  • Invest in R&D: Explore formulation enhancements or new indications to extend patent life or justify premium pricing.
  • Regional Market Adaptation: Tailor pricing strategies based on regional regulations, competition, and payer models.

Key Takeaways

  • Stable Market With Potential for Price Erosion: The current market for NDC 83301-0005 remains stable, but upcoming patent expirations may lead to significant discounts.
  • Demand Driven by Therapeutic Needs: Rising prevalence of [condition] sustains strong demand, supporting premium pricing pre-expiry.
  • Competitive Landscape Critical: Entry of biosimilars and generics will substantially influence future pricing strategies.
  • Regulatory Environment’s Role: Changes in pricing regulation and reimbursement policies will shape the trajectory of drug pricing.
  • Proactive Strategy Essential: Stakeholders should proactively monitor patent timelines, market entry, and regulatory developments to optimize financial outcomes.

FAQs

1. What are the main factors influencing the price of NDC 83301-0005?
Market demand, patent status, competition, regulatory policies, and manufacturing costs primarily drive pricing. Patent expirations and biosimilar entries exert downward pressure, while demand and exclusivity periods support higher prices.

2. How does biosimilar competition impact the market for this drug?
Biosimilars typically reduce prices by 30-50%, increasing access but decreasing margins for original patent holders. Their arrival usually results in substantial price erosion over a 1-3 year period post-approval.

3. What regulatory changes could affect future pricing?
Implementation of cost-effectiveness assessments, price caps, or value-based reimbursement models can limit price escalation, while streamlined approval processes might accelerate market entry of competitors.

4. Which regions offer the highest pricing opportunities?
Developed markets like North America and select European countries tend to sustain higher prices due to favorable reimbursement policies and higher healthcare spending. Emerging markets may present volume opportunities but with lower price points.

5. How should stakeholders prepare for future price trends?
Stakeholders should monitor patent timelines, regulatory developments, and competitive dynamics continually. Investing in lifecycle management, optimizing supply chains, and engaging with payers can mitigate adverse price impacts.

References

  1. [Insert detailed references for demand data, pricing trends, competitor analysis, and regulatory information]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.